Skip to main content

Regulatory and Washington

  • CVS Caremark’s Reid reiterates support of biogeneric drugs in the Affordable Care Act

    WOONSOCKET, R.I. In testimony before the Food and Drug Administration on Tuesday, CVS Caremark’s SVP specialty pharmacy operations, Scott Reid, reiterated the company’s support that the FDA implement regulations necessary to approve biogeneric drugs under the Affordable Care Act.

  • In letter, NACDS thanks senator for supporting Tricare

    ALEXANDRIA A group representing the drug retailing industry commended a senator's support of the military healthcare program Tricare.

  • NACDS Foundation supports NCL's medication adherence awareness campaign

    ALEXANDRIA, Va. The charitable arm of the National Association of Chain Drug Stores announced its $1 million contribution to the National Consumers League's medication adherence awareness campaign.

     

  • Congress targets Rx abuse with pharm’s backing

    With strong support from pharmacy leaders, Congress is moving to shut down prescription medication abuse and diversion with a multipronged legislative cudgel.

    Prior to its October recess, the U.S. House of Representatives passed three industry-backed bills in September to help seal up the nation’s leaky prescription drug pipeline. The bills are expected to pass under “suspension of the rules,” which allows for expedited consideration of legislation.

  • New Lo Loestrin Fe gets FDA approval

    ARDEE, Ireland The Food and Drug Administration has approved a new contraceptive from Warner Chilcott, the drug maker said Friday.

     

    The company said it plans to launch Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) early next year. The company said the contraceptive contains the lowest dosage of estrogen — 10 micrograms — of any oral contraceptive currently available in the U.S. market.

     

     

  • NACDS encourages members to use RollStream's CEN to assure CPSIA compliance

    ALEXANDRIA, Va. A group representing the nation's chain pharmacies alerted retailers and manufacturers Thursday about a new rule, part of the Consumer Product Safety Improvement Act, that requires tracking labels on certain products.

  • NACDS addresses medication adherence at Senate Health Fair

    WASHINGTON The National Association of Chain Drug Stores emphasized the importance of pharmacy-patient interaction at this year's Senate Health Fair, held last week in Washington, D.C.

  • Cardiovascular, diabetes risk associated with prostate cancer drug class

    SILVER SPRING, Md. Patients taking a certain class of drugs mostly used for prostate cancer may be at higher risk of heart disease and diabetes, the Food and Drug Administration warned on Wednesday.

     

X
This ad will auto-close in 10 seconds